Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nurlan Mammadzada
Observed names:
N. Mammadzada,
Nurlan MAMMADZADA
Institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
Sağlık Bilimleri Üniversitesi,
Gülhane Eğitim ve Araştırma Hastanesi,
The Ohio State University
Observed institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
Gülhane Askerî Tıp Akademisi,
Sağlık Bilimleri Üniversitesi,
Gülhane Eğitim ve Araştırma Hastanesi,
The Ohio State University
ORCID:
0000-0003-1981-7144
Observed ORCID:
0000-0003-1981-7144
OpenAlex ID:
A5020288228
Salvage Treatment for Extragonadal Germ Cell Tumours: High-Dose Chemotherapy and Autologous Stem Cell Transplantation Outcomes—A Single-Centre Experience
2024
·
Alper TOPAL
, Ismail ERTURK
, et al.
·
Journal of Clinical Medicine
·
2
PDF
Pre-Transplant Prognostic Nutritional Index Independently Predicts Progression-Free Survival After Autologous Stem Cell Transplantation in Lymphoma
2026
·
Hüseyin Atacan
, Volkan Aslan
, et al.
·
Journal of Clinical Medicine
·
1
PDF
Electroencephalographic findings and 5‐year risk of posttraumatic epilepsy after mild traumatic brain injury: Insights from Second Karabakh War veterans
2026
·
Javid Shafiyev
, Ömer Karadaş
, et al.
·
Epilepsia
·
1
PDF
Impact of Testicular Germ Cell Tumor Laterality on Survival After Autologous Stem Cell Transplantation and High-Dose Chemotherapy
2025
·
Alper Topal
, Ayşegül Dumludağ
, et al.
·
Istanbul Medical Journal
·
1
PDF
Primary vulvovaginal choriocarcinoma patient who underwent autologous hematopoetic stem cell transplantation: A case report of unusual presentation
2018
·
Ramazan Esen
, Nurlan Mammadzada
, et al.
·
Eastern Journal Of Medicine
·
1
PDF
Prognostic significance of teratoma components in germ cell tumor patients undergoing high-dose chemotherapy and autologous stem cell transplantation.
2026
·
Nurlan Mammadzada
, Berkan Karadurmus
, et al.
·
Journal of Clinical Oncology
Efficacy of high-dose chemotherapy in adult patients with relapsed or refractory medulloblastoma.
2026
·
Nurlan Mammadzada
, Berkan Karadurmus
, et al.
·
Journal of Clinical Oncology
PDF
Real-world overall survival outcomes of lutetium (Lu 177 ) vipivotide tetraxetan treatment in prostate cancer.
2026
·
Elshad Hasanov
, Antonio Faieta
, et al.
·
Journal of Clinical Oncology
Assessment of Meet-URO and CANLPH Prognostic Models in Metastatic RCC: Insights from a Single-Institution Cohort Predominantly Treated with TKIs
2026
·
Ömer Faruk Kuzu
, Nuri Karadurmuş
, et al.
·
Diagnostics
PDF
Real-World Survival Outcomes and Risk Prediction Model in Prostate Cancer Treated with ¹⁷⁷Lu-PSMA617
2026
·
Bayan Abu Alragheb
, Nurlan Mammadzada
, et al.
·
SSRN Electronic Journal
PDF
1059P Clinical characteristics and treatment outcomes in patients with malignant somatic transformation of germ cell tumors
2025
·
N. Mammadzada
, N. Karadurmus
, et al.
·
Annals of Oncology
Unaccounted clinical factors in CINV outcomes: the missing role of IO therapy, metastatic sites, and prophylaxis strategy
2025
·
Nurlan Mammadzada
, Kadriye Başkurt
, et al.
·
Supportive Care in Cancer
Letter to the Editor: Comment on “Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy”
2025
·
Kadriye Başkurt
, Berkan Karabuğa
, et al.
·
Nutrition and Cancer
Letter RE: Somatic BRCA1/2 mutations are associated with a similar survival advantage to their germline counterparts in tubo-ovarian high-grade serous carcinoma
2025
·
Berkan Karabuga
, Kadriye Baskurt
, et al.
·
European Journal of Cancer
Sedentary behavior and associated factors on admissions to internal medicine wards
2024
·
Nurlan Mammadzada
, Ilker Tasci
·
Internal and Emergency Medicine
Show more works
View as search
Works count:
15
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type